<!DOCTYPE html>
<html lang="en" data-theme="light">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>FBIO Shares Rally After Unit Sells Priority Review Voucher For $205 Million: Retail Now Pins Hopes On Gene Therapy | Ultimatrix</title>
  <link rel="icon" type="image/png" href="/assets/img/favicon.png" />
  <link rel="stylesheet" href="/css/style.css" />
  <link rel="stylesheet" href="/css/blogs.css" />
  <link rel="stylesheet" href="/css/news-sports.css" />
  <link rel="stylesheet" href="/css/news-sports-pages.css" />
  <script src="/js/script.js" defer></script>
    <script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-9364127030923496"
     crossorigin="anonymous"></script>
</head>
<body>
  <div id="header"></div>
  <main>
    <section class="section-main">
      <article id="news-article" data-headline="false">
        <h1 id="news-title">FBIO Shares Rally After Unit Sells Priority Review Voucher For $205 Million: Retail Now Pins Hopes On Gene Therapy</h1>
        <h2 id="news-short-desc">Fortress said that its majority-owned unit Cyprium Therapeutics has entered into a definitive asset purchase agreement to sell its Rare Pediatric Disease Priority Review Voucher to Sentynl Therapeutics.</h2>
        <p id="news-timestamp" class="timestamp">2026-02-23 17:30:06</p>
      </article>
      <section class="news-full-story">
        <h2>Full Story</h2>
        <p id="news-link"><a href="https://newsable.asianetnews.com/markets/fbio-shares-rally-after-unit-sells-priority-review-voucher-for-205-million-retail-now-pins-hopes-on-gene-therapy-articleshow-0109igy">Read Here: https://newsable.asianetnews.com/markets/fbio-shares-rally-after-unit-sells-priority-review-voucher-for-205-million-retail-now-pins-hopes-on-gene-therapy-articleshow-0109igy</a></p>        
      </section>
      <section class="article-footer">
        <p>üñäÔ∏è Written by: <strong>Ultimatrix Team</strong></p>
        <p>üì° Source: <a href="https://newsable.asianetnews.com">https://newsable.asianetnews.com</a></p>
        <p>üìú Legal Disclaimer: This article is for informational purposes only. All facts are accurate to the best of our knowledge at time of publication. Reproduction without permission is prohibited.</p>
      </section>
    </section>
  </main>
  <div id="footer"></div>
</body>
</html>